§ Funding Round
Series B funding round for Imbria Pharmaceuticals raising $59M in April 2025
Series B funding round for Imbria Pharmaceuticals raising $59M in April 2025
| Investor | Firm Type | Partner |
|---|---|---|
| Organization | — | |
RA Capital | — | — |
| Organization | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$59M
Top Valuation
-
Imbria Pharmaceuticals raised $59M in a Series B round.
The round was announced on 04/01/25.
The round was led by deep track capital.
